Skip to main content

Fenwick Represents HealthLeap in $38M Seed and Series A Funding

EXPERIENCE Banner Image

Fenwick represented HealthLeap, a clinical AI platform that screens patients for conditions that often go undiagnosed, in its combined $38M seed and Series A funding. The round included participation from Sequoia Capital, First Round Capital, and Hummingbird Ventures.

HealthLeap will use the funds to expand to more conditions and grow its engineering, sales, customer success, and product teams. More information can be obtained from the company announcement.

The Fenwick transaction team was led by corporate partners Michael Esquivel and Christopher Crawford and included associates Anja Kong, Kaylee Johnson, and Connor Haney.